Tuesday January 16th 2018

Archive for March, 2011

Concerns about controversial MS treatment

Concerns about controversial MS treatment

An investigation by BBC Inside Out discovered that one doctor carrying out the procedure in Egypt is not licensed to practice medicine in that country. The BBC understands that in the UK, an NHS GP has been reported to the doctors’ watchdog, the General Medical [Read More]

‘MS experts in Britain have to open their minds’

‘MS experts in Britain have to open their minds’

Last July, The Telegraph reported on the battle by MS sufferer Mark Walker to have a controversial new treatment not recognised in Britain. Here, he tells how his condition has improved since having it abroad . My wife’s reaction when she touched my feet on July 1 2010 [Read More]

Alberta doctors advised how to treat MS liberation patients

Alberta doctors advised how to treat MS liberation patients

Alberta doctors are being told there isn’t a lot of information on how to provide followup care for multiple sclerosis patients who have undergone an unproven procedure outside the country. A document written by a committee of doctors and circulated by the [Read More]

 Page 5 of 6  « First  ... « 2  3  4  5  6 »

Latest Topics

FDA Denies Health Claim for Vitamin D to Prevent MS FDA Denies Health Claim for Vitamin D to Prevent MS

FDA Denies Health Claim for Vitamin D to Prevent MS FDA Denies Health Claim for Vitamin D to Prevent MS

The FDA responded to a petition, saying that after reviewing the evidence, there is no basis for the claim that vitamin [Read More]

Effects of sport climbing on multiple sclerosis – Steimer J, Weissert R.

Effects of sport climbing on multiple sclerosis – Steimer J, Weissert R.

Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease of the central nervous system (CNS) with [Read More]

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

Researchers use novel PET tracer to assess myelin damage in mouse models of MS

The loss or damage of myelin, a cellular sheath that surrounds and insulates nerves, is the hallmark of the [Read More]

MS Drug Ocrelizumab (Ocrevus) Approved in Europe MS Drug Ocrelizumab (Ocrevus) Approved in Europe

MS Drug Ocrelizumab (Ocrevus) Approved in Europe MS Drug Ocrelizumab (Ocrevus) Approved in Europe

The European Commission clears the anti-CD20 monoclonal antibody for adults with relapsing multiple sclerosis and early [Read More]

New PET radiotracer offers insight into multiple sclerosis

New PET radiotracer offers insight into multiple sclerosis

Combining PET scans with a novel radiotracer could help researchers track damage...Read more on AuntMinnie.comRelated [Read More]